PFG Investments LLC boosted its stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the Securities ...

Accurate Wealth Management LLC acquired a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) during the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.8%. Now it makes sense why the stock has been powering to new ...

The RELIEF ureteral stent is the first FDA-cleared stent for vesicoureteral reflux prevention in the US. The stent's design minimizes bladder spasms and reflux, improving patient comfort compared to ...

The RELIEF ureteral stent, the brainchild of Dr. Lee Ponsky, chairman of UH’s Urology Institute, has been cleared by the U.S. Food and Drug Administration for preventing vesicoureteral reflux, a major ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s ...

The exciting scientific developments present threats as well as opportunities. Dozens of leading researchers including two Nobel Prize winners have warned of the potentially catastrophic impact of ...

Conclusion: The placement of ureteral stents has become a common procedure in the management of various obstructive pathological processes of the urinary tract.